A Review of Bayesian Perspectives on Sample Size Derivation for Confirmatory Trials

Estimation of clinical trial success rates and related parameters

(2018) Chi Heem Wong et al.   BIOSTATISTICS

Statistical power of clinical trials increased while effect size remained stable: an empirical analysis of 136,212 clinical trials between 1975-2014

(2018) Herm J. Lamberink et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Better decision making in drug development through adoption of formal prior elicitation

(2018) Nigel Dallow et al.   PHARMACEUTICAL STATISTICS

Predictive probability of success using surrogate endpoints

(2018) Gaelle Saint‐Hilary et al.   STATISTICS IN MEDICINE

DELTA2 guidance on choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial

(2018) Jonathan A Cook et al.   BMJ-British Medical Journal

Innovation in the pharmaceutical industry: New estimates of R&D costs

(2016) Joseph A. DiMasi et al.   JOURNAL OF HEALTH ECONOMICS

Bayesian predictive power: choice of prior and some recommendations for its use as probability of success in drug development

(2016) Kaspar Rufibach et al.   PHARMACEUTICAL STATISTICS

Selection of the treatment effect for sample size determination in a superiority clinical trial using a hybrid classical and Bayesian procedure

(2015) Maria M. Ciarleglio et al.   Contemporary Clinical Trials

Twenty-five years of confirmatory adaptive designs: opportunities and pitfalls

(2015) Peter Bauer et al.   STATISTICS IN MEDICINE

Structured approach to the elicitation of expert beliefs for a Bayesian-designed clinical trial: a case study

(2013) Nelson Kinnersley et al.   PHARMACEUTICAL STATISTICS

Some thoughts on sample size: A Bayesian-frequentist hybrid approach

(2012) KK Gordan Lan et al.   Clinical Trials

An Extension of Bayesian Expected Power and Its Application in Decision Making

(2010) Fang Liu   Journal of Biopharmaceutical Statistics

The role of the minimum clinically important difference and its impact on designing a trial

(2010) Christy Chuang-Stein et al.   PHARMACEUTICAL STATISTICS

A hybrid Bayesian-frequentist approach to evaluate clinical trial designs for tests of superiority and non-inferiority

(2007) Yongzhao Shao et al.   STATISTICS IN MEDICINE